Through the use of antibodies that target distinct phosphorylated patterns within the amino acid sequence of tau (referred to as p-tau), some isoforms of p-tau (namely p-tau181,−199, and−231) have been identified as exhibiting a greater association with AD. This evidence concerns the gene MAPT and Alzheimer disease.